Erasca (ERAS) Cash from Financing Activities (2020 - 2026)

Erasca (ERAS) reported Cash from Financing Activities of $244.7 million for Q1 2026, up 741306.06% on a YoY basis from N/an in Q1 2025, and up 42450.26% quarter-over-quarter from $575000.0 in Q4 2025.

Erasca (ERAS) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Erasca has reported Cash from Financing Activities for 7 years, with the latest figure at $244.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 741306.06% year-over-year to $244.7 million; the trailing twelve-month figure through Mar 2026 stood at $245.7 million (up 5.1% YoY), and the FY2025 full-year result was $1.1 million, down 99.54% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $244.7 million, up from $575000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $244.7 million in Q1 2026, with the low at $7000.0 in Q3 2023.
  • Historically, Cash from Financing Activities has averaged $34.5 million across 5 years, with a median of $575000.0 in 2025.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 99.87% — and 2026, when it surged 741306.06%.
  • Erasca's Cash from Financing Activities stood at $96.2 million in 2022, then plunged by 99.53% to $456000.0 in 2023, then jumped by 75.66% to $801000.0 in 2024, then retreated by 28.21% to $575000.0 in 2025, then jumped by 42450.26% to $244.7 million in 2026.
  • The last three Cash from Financing Activities figures came in at $244.7 million (Q1 2026), $575000.0 (Q4 2025), and $41000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Erasca 4.16 Bn 3.92 Bn - 244.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 244.66 Mn
Mar 31, 2026 244.66 Mn
Dec 31, 2025 575,000.00
Dec 31, 2025 575,000.00
Sep 30, 2025 41,000.00
Sep 30, 2025 41,000.00
Jun 30, 2025 447,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 33,000.00
Mar 31, 2025 33,000.00
Dec 31, 2024 801,000.00
Dec 31, 2024 801,000.00
Sep 30, 2024 21.10 Mn
Sep 30, 2024 21.10 Mn
Jun 30, 2024 211.87 Mn
Jun 30, 2024 211.87 Mn
Mar 31, 2024 6.93 Mn
Mar 31, 2024 6.93 Mn
Dec 31, 2023 456,000.00
Dec 31, 2023 456,000.00